Plasma growth differentiation factor-15 in children with pulmonary hypertension associated with congenital heart disease: A canary in the mine?
D El Amrousy, E Zahran, H El-Serogy, A Zoair - Progress in Pediatric …, 2020 - Elsevier
We aimed to investigate the prognostic values of plasma growth differentiation factor-15 to
predict adverse outcome in children with pulmonary hypertension associated with
congenital heart disease. Forty children with pulmonary hypertension associated with
congenital heart disease were enrolled as group I and 40 patients with congenital heart
disease and no pulmonary hypertension of matched age, sex and type of congenital heart
disease were enrolled as group II. Forty healthy children of matched age and sex served as …
predict adverse outcome in children with pulmonary hypertension associated with
congenital heart disease. Forty children with pulmonary hypertension associated with
congenital heart disease were enrolled as group I and 40 patients with congenital heart
disease and no pulmonary hypertension of matched age, sex and type of congenital heart
disease were enrolled as group II. Forty healthy children of matched age and sex served as …
以上显示的是最相近的搜索结果。 查看全部搜索结果